OpenURL Connection Search

Select item for more details and to access through your institution.

Radiosynthesis, ex vivo and in vivo evaluation of [11C]preclamol as a partial dopamine D2 agonist radioligand for positron emission tomography.
Published in:
Synapse, 2006, v. 60, n. 4, p. 314, doi. 10.1002/syn.20304
By:
- Vasdev, Neil;
- Natesan, Sridhar;
- Galineau, Laurent;
- Garcia, Armando;
- Stableford, Winston T.;
- McCormick, Patrick;
- Seeman, Philip;
- Houle, Sylvain;
- Wilson, Alan A.
Publication type:
Article
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.
Published in:
Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-14122-0
By:
- Onwordi, Ellis Chika;
- Halff, Els F.;
- Whitehurst, Thomas;
- Mansur, Ayla;
- Cotel, Marie-Caroline;
- Wells, Lisa;
- Creeney, Hannah;
- Bonsall, David;
- Rogdaki, Maria;
- Shatalina, Ekaterina;
- Reis Marques, Tiago;
- Rabiner, Eugenii A.;
- Gunn, Roger N.;
- Natesan, Sridhar;
- Vernon, Anthony C.;
- Howes, Oliver D.
Publication type:
Article
Adenosine A2A receptor in schizophrenia: an in vivo brain PET imaging study.
Published in:
Psychopharmacology, 2022, v. 239, n. 11, p. 3439, doi. 10.1007/s00213-021-05900-0
By:
- Marques, Tiago Reis;
- Natesan, Sridhar;
- Rabiner, Eugenii A.;
- Searle, Graham E.;
- Gunn, Roger;
- Howes, Oliver D.;
- Kapur, Shitij
Publication type:
Article
Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [18F]BCPP-EF PET study.
Published in:
EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01099-1
By:
- Shatalina, Ekaterina;
- Whitehurst, Thomas S.;
- Onwordi, Ellis Chika;
- Gilbert, Barnabas J.;
- Rizzo, Gaia;
- Whittington, Alex;
- Mansur, Ayla;
- Tsukada, Hideo;
- Marques, Tiago Reis;
- Natesan, Sridhar;
- Rabiner, Eugenii A.;
- Wall, Matthew B.;
- Howes, Oliver D.
Publication type:
Article
The antipsychotic potential of l-stepholidine—a naturally occurring dopamine receptor D1 agonist and D2 antagonist.
Published in:
Psychopharmacology, 2008, v. 199, n. 2, p. 275, doi. 10.1007/s00213-008-1172-1
By:
- Natesan, Sridhar;
- Reckless, Greg;
- Barlow, Karen;
- Odontiadis, John;
- Nobrega, José;
- Baker, Glen;
- George, Susan;
- Mamo, David;
- Kapur, Shitij
Publication type:
Article
Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.
Published in:
2015
By:
- Niccolini, Flavia;
- Haider, Salman;
- Marques, Tiago Reis;
- Muhlert, Nils;
- Tziortzi, Andri C.;
- Searle, Graham E.;
- Natesan, Sridhar;
- Piccini, Paola;
- Kapur, Shitij;
- Rabiner, Eugenii A.;
- Gunn, Roger N.;
- Tabrizi, Sarah J.;
- Politis, Marios;
- Reis Marques, Tiago
Publication type:
journal article
Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.
Published in:
2015
By:
- Niccolini, Flavia;
- Foltynie, Thomas;
- Marques, Tiago Reis;
- Muhlert, Nils;
- Tziortzi, Andri C.;
- Searle, Graham E.;
- Natesan, Sridhar;
- Kapur, Shitij;
- Rabiner, Eugenii A.;
- Gunn, Roger N.;
- Piccini, Paola;
- Politis, Marios;
- Reis Marques, Tiago
Publication type:
journal article
Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.
Published in:
Molecular Imaging, 2024, p. 1, doi. 10.1155/2022/4419221
By:
- Halff, Els F.;
- Natesan, Sridhar;
- Bonsall, David R.;
- Veronese, Mattia;
- Garcia-Hidalgo, Anna;
- Kokkinou, Michelle;
- Tang, Sac-Pham;
- Riggall, Laura J.;
- Gunn, Roger N.;
- Irvine, Elaine E.;
- Withers, Dominic J.;
- Wells, Lisa A.;
- Howes, Oliver D.;
- Vasdev, Neil
Publication type:
Article
Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.
Published in:
Molecular Imaging, 2022, v. 2022, p. 1, doi. 10.1155/2022/4419221
By:
- Halff, Els F.;
- Natesan, Sridhar;
- Bonsall, David R.;
- Veronese, Mattia;
- Garcia-Hidalgo, Anna;
- Kokkinou, Michelle;
- Tang, Sac-Pham;
- Riggall, Laura J.;
- Gunn, Roger N.;
- Irvine, Elaine E.;
- Withers, Dominic J.;
- Wells, Lisa A.;
- Howes, Oliver D.
Publication type:
Article
Correction: Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.
Published in:
2024
By:
- Petty, Alice;
- Garcia-Hidalgo, Anna;
- Halff, Els F.;
- Natesan, Sridhar;
- Withers, Dominic J.;
- Irvine, Elaine E.;
- Kokkinou, Michelle;
- Wells, Lisa A.;
- Bonsall, David R.;
- Tang, Sac-Pham;
- Veronese, Mattia;
- Howes, Oliver D.
Publication type:
Correction Notice
Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.
Published in:
Molecular Imaging & Biology, 2023, v. 25, n. 6, p. 1054, doi. 10.1007/s11307-023-01865-y
By:
- Petty, Alice;
- Garcia-Hidalgo, Anna;
- Halff, Els F;
- Natesan, Sridhar;
- Withers, Dominic J;
- Irvine, Elaine E;
- Kokkinou, Michelle;
- Wells, Lisa A;
- Bonsall, David R;
- Tang, Sac-Pham;
- Veronese, Mattia;
- Howes, Oliver D
Publication type:
Article
Partial agonists in schizophrenia – why some work and others do not: insights from preclinical animal models.
Published in:
International Journal of Neuropsychopharmacology, 2011, v. 14, n. 9, p. 1165, doi. 10.1017/S1461145710001343
By:
- Natesan, Sridhar;
- Reckless, Greg E.;
- Barlow, Karen B. L.;
- Nobrega, José N.;
- Kapur, Shitij
Publication type:
Article
Evaluation of N-Desmethylclozapine as a Potential Antipsychotic—Preclinical Studies.
Published in:
Neuropsychopharmacology, 2007, v. 32, n. 7, p. 1540, doi. 10.1038/sj.npp.1301279
By:
- Natesan, Sridhar;
- Reckless, Greg E.;
- Barlow, Karen B. L.;
- Nobrega, José N.;
- Kapur, Shitij
Publication type:
Article
Dissociation between In Vivo Occupancy and Functional Antagonism of Dopamine D2 Receptors: Comparing Aripiprazole to Other Antipsychotics in Animal Models.
Published in:
Neuropsychopharmacology, 2006, v. 31, n. 9, p. 1854, doi. 10.1038/sj.npp.1300983
By:
- Natesan, Sridhar;
- Reckless, Greg E.;
- Nobrega, José N.;
- Fletcher, Paul J.;
- Kapur, Shitij
Publication type:
Article
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse.
Published in:
Schizophrenia Bulletin, 2021, v. 47, n. 4, p. 1116, doi. 10.1093/schbul/sbab017
By:
- Horowitz, Mark Abie;
- Jauhar, Sameer;
- Natesan, Sridhar;
- Murray, Robin M;
- Taylor, David
Publication type:
Article
SYNAPTIC MARKER PROTEIN SV2A IS REDUCED IN SCHIZOPHRENIA IN VIVO AND UNAFFECTED BY ANTIPSYCHOTICS IN RATS.
Published in:
Schizophrenia Bulletin, 2020, v. 46, p. S28, doi. 10.1093/schbul/sbaa028.063
By:
- Chika Onwordi, Ellis;
- Halff, Els;
- Whitehurst, Thomas;
- Mansur, Ayla;
- Cotel, Marie-Caroline;
- Wells, Lisa;
- Creeney, Hannah;
- Bonsall, David;
- Rogdaki, Maria;
- Shatalina, Ekaterina;
- Reis Marques, Tiago;
- Rabiner, Eugenii;
- Gunn, Roger;
- Natesan, Sridhar;
- Vernon, Anthony;
- Howes, Oliver D.
Publication type:
Article
Phosphodiesterase 10A PET Radioligand Development Program: From Pig to Human.
Published in:
Journal of Nuclear Medicine, 2014, v. 55, n. 4, p. 595, doi. 10.2967/jnumed.113.131409
By:
- Plisson, Christophe;
- Weinzimmer, David;
- Jakobsen, Steen;
- Natesan, Sridhar;
- Salinas, Cristian;
- Shu-Fei Lin;
- Labaree, David;
- Ming-Qiang Zheng;
- Nabulsi, Nabeel;
- Marques, Tiago Reis;
- Shitij Kapur;
- Eiji Kawanishi;
- Takeaki Saijo;
- Gunn, Roger N.;
- Carson, Richard E.;
- Rabiner, Eugenii A.
Publication type:
Article

Found: 17

Radiosynthesis, ex vivo and in vivo evaluation of [<sup>11</sup>C]preclamol as a partial dopamine D2 agonist radioligand for positron emission tomography.

Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.

Adenosine A<sub>2A</sub> receptor in schizophrenia: an in vivo brain PET imaging study.

Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [<sup>18</sup>F]BCPP-EF PET study.

The antipsychotic potential of l-stepholidine—a naturally occurring dopamine receptor D<sub>1</sub> agonist and D<sub>2</sub> antagonist.

Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.

Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.

Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.

Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.

Correction: Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.

Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.

Partial agonists in schizophrenia – why some work and others do not: insights from preclinical animal models.

Evaluation of N-Desmethylclozapine as a Potential Antipsychotic—Preclinical Studies.

Dissociation between In Vivo Occupancy and Functional Antagonism of Dopamine D<sub>2</sub> Receptors: Comparing Aripiprazole to Other Antipsychotics in Animal Models.

A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse.

SYNAPTIC MARKER PROTEIN SV2A IS REDUCED IN SCHIZOPHRENIA IN VIVO AND UNAFFECTED BY ANTIPSYCHOTICS IN RATS.

Phosphodiesterase 10A PET Radioligand Development Program: From Pig to Human.